Financial report interval: 2025.12.30 - 2026.06.30
Overview: GENSCRIPT BIO(01548) the Revenue is 3.169 B (-22.18%), Beat estimate;the EBIT is 393.35 M (-71.96%), Beat estimate;the EPS is -0.464 (-173.8%), Miss estimate.